Palo Alto, CA, United States of America

Matthew Lean


Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Matthew Lean: Innovator in Research Study Management

Introduction

Matthew Lean is an accomplished inventor based in Palo Alto, CA. He has made significant contributions to the field of research study management through his innovative patent. His work focuses on enhancing the efficiency and effectiveness of research studies by utilizing mobile and web technologies.

Latest Patents

Matthew Lean holds a patent for "Methods and systems for creating and managing a research study and deploying via mobile and web utilizing a research module." This patent outlines systems and methods for generating a research study application. The process begins with a request from a user to generate a research study. A variety of task generation options are presented on a graphical user interface of an electronic device. These options include a consent survey, an eligibility survey, a medical history survey, and a medical tracking survey. Input regarding these options is received from the user, leading to the generation of a research study application based on the information provided.

Career Highlights

Matthew Lean is currently employed at Medable Inc., a company that specializes in advancing clinical research through innovative technology solutions. His role at Medable allows him to apply his expertise in research study management and contribute to the development of cutting-edge applications.

Collaborations

Some of Matthew's notable coworkers include Michelle Longmire and Ingrid Oakley-Girvan. Their collaboration fosters a dynamic environment that encourages innovation and the sharing of ideas.

Conclusion

Matthew Lean's contributions to research study management through his patent and work at Medable Inc. highlight his role as an innovator in the field. His efforts are paving the way for more efficient research processes, ultimately benefiting the scientific community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…